ifosfamide has been researched along with HIV Coinfection in 12 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The toxicity of dose-intensive regimens used for Burkitt lymphoma prompted modification of cyclophosphamide, vincristine, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for HIV-positive patients." | 5.20 | AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma. ( Ambinder, R; Baiocchi, R; Cesarman, E; Kaplan, L; Lee, JY; Noy, A; Ratner, L; Reid, E; Wagner-Johnston, N, 2015) |
| "Treatment options for Burkitt's lymphoma involve complex chemotherapy regimens that contain as many as 10 cytotoxic agents." | 2.41 | Challenges in the management of Burkitt's lymphoma. ( Levine, AM, 2002) |
| "Burkitt lymphoma is an aggressive B cell malignancy accounting for 1-2% of all adult lymphomas." | 1.48 | Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens. ( Baars, JW; Brouwer, R; Chamuleau, MED; de Jong, D; de Wreede, LC; Demandt, AMP; Doorduijn, JK; Hardi, L; Kersten, MJ; Kluin, PM; Nijland, M; Oosten, LEM; Siemes, C; Smeekes, OS; Stevens, WBC; Thielen, FW; Uyl-de Groot, CA; van Imhoff, GW; Veelken, H, 2018) |
| " Much attention has focussed on pharmacokinetic interactions attributable to effects on hepatic microsomal enzymes, but not on competition for the renal organic anion transport system." | 1.43 | The pharmacokinetics of high-dose methotrexate in people living with HIV on antiretroviral therapy. ( Bendle, M; Boffito, M; Bower, M; Dalla Pria, A; Ramaswami, R, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oosten, LEM | 1 |
| Chamuleau, MED | 1 |
| Thielen, FW | 1 |
| de Wreede, LC | 1 |
| Siemes, C | 1 |
| Doorduijn, JK | 1 |
| Smeekes, OS | 1 |
| Kersten, MJ | 1 |
| Hardi, L | 1 |
| Baars, JW | 1 |
| Demandt, AMP | 1 |
| Stevens, WBC | 1 |
| Nijland, M | 1 |
| van Imhoff, GW | 1 |
| Brouwer, R | 1 |
| Uyl-de Groot, CA | 1 |
| Kluin, PM | 1 |
| de Jong, D | 1 |
| Veelken, H | 1 |
| Reid, EG | 1 |
| Looney, D | 1 |
| Maldarelli, F | 1 |
| Noy, A | 2 |
| Henry, D | 1 |
| Aboulafia, D | 1 |
| Ramos, JC | 1 |
| Sparano, J | 1 |
| Ambinder, RF | 1 |
| Lee, J | 1 |
| Cesarman, E | 2 |
| Yahyaei, S | 1 |
| Mitsuyasu, R | 1 |
| Wachsman, W | 1 |
| Lee, JY | 1 |
| Ambinder, R | 1 |
| Baiocchi, R | 1 |
| Reid, E | 1 |
| Ratner, L | 1 |
| Wagner-Johnston, N | 1 |
| Kaplan, L | 1 |
| Dalla Pria, A | 1 |
| Bendle, M | 1 |
| Ramaswami, R | 1 |
| Boffito, M | 1 |
| Bower, M | 1 |
| Saha, D | 1 |
| Basu, A | 1 |
| Maiti, A | 1 |
| Rodriguez, E | 1 |
| Berretta, M | 1 |
| Zanet, E | 1 |
| Taibi, R | 1 |
| Martellotta, F | 1 |
| Pavone, P | 1 |
| Bearz, A | 1 |
| Gobitti, C | 1 |
| Ciancia, EM | 1 |
| Canzonieri, V | 1 |
| Tirelli, U | 1 |
| Govender, PS | 1 |
| Barnes, JA | 1 |
| Lacasce, AS | 1 |
| Feng, Y | 1 |
| Toomey, CE | 1 |
| Neuberg, D | 1 |
| Michaelson, JS | 1 |
| Hochberg, EP | 1 |
| Abramson, JS | 1 |
| Levine, AM | 1 |
| Fan, SK | 1 |
| Wang, YG | 1 |
| Shimomura, A | 1 |
| Lilienfeld-Toal, Mv | 1 |
| Balta, Z | 1 |
| Schroers, E | 1 |
| Schmidt-Wolf, IG | 1 |
| Büttner, R | 1 |
| Rücker, Av | 1 |
| Gütgemann, I | 1 |
| Jambusaria, A | 1 |
| Shafer, D | 1 |
| Wu, H | 1 |
| Al-Saleem, T | 1 |
| Perlis, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Safety and Efficacy Pilot Trial of the Anti-Viral and Anti-Tumor Activity of Velcade Combined With (R)ICE in Subjects With EBV and/or HHV-8 Positive Relapsed/Refractory AIDS-Associated Non-Hodgkin's Lymphoma[NCT00598169] | Phase 1 | 23 participants (Actual) | Interventional | 2007-11-30 | Completed | ||
| Prospective Phase II Study of a High Dose, Short Course Regimen (R-CODOX-M/IVAC) Including CNS Penetration and Intensive IT Prophylaxis in HIV-Associated Burkitt's and Atypical Burkitt's Lymphoma[NCT00392834] | Phase 2 | 34 participants (Actual) | Interventional | 2006-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00392834)
Timeframe: 1 year post treatment
| Intervention | Cumulative proportion surviving at 1 yr (Number) |
|---|---|
| Regimen A (R-CODOX-M Chemotherapy) | 1.0 |
| Regimen B (Rituximab and IVAC Chemotherapy) | 0.82 |
2 reviews available for ifosfamide and HIV Coinfection
| Article | Year |
|---|---|
Leiomyosarcoma of the parotid gland in an HIV-positive patient: therapeutic approach, clinical course and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Biomar | 2009 |
Challenges in the management of Burkitt's lymphoma.
Topics: Adult; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly A | 2002 |
2 trials available for ifosfamide and HIV Coinfection
| Article | Year |
|---|---|
Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; APOBEC-3G Deaminase; Bortezomib; Carbop | 2018 |
AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antir | 2015 |
8 other studies available for ifosfamide and HIV Coinfection
| Article | Year |
|---|---|
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carmustin | 2018 |
The pharmacokinetics of high-dose methotrexate in people living with HIV on antiretroviral therapy.
Topics: Adult; Aged; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cycl | 2016 |
Primary proximal epithelioid sarcoma of the lung successfully treated with pneumonectomy and adjuvant chemotherapy.
Topics: Adult; Chemotherapy, Adjuvant; Doxorubicin; Hemoptysis; HIV Infections; Humans; Ifosfamide; Lung Neo | 2016 |
Atypical presentation of angiosarcoma of the scalp in the setting of human immunodeficiency virus (HIV).
Topics: Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Combine | 2009 |
Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherap | 2011 |
Decision-theoretic designs for dose-finding clinical trials with multiple outcomes.
Topics: Algorithms; Anti-HIV Agents; Antineoplastic Agents, Alkylating; Child, Preschool; Clinical Trials, P | 2006 |
Absent immunoglobulins in HIV-related Burkitt lymphoma/leukaemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; B-Lymphocytes | 2008 |
Cutaneous plasmablastic lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposid | 2008 |